Suppr超能文献

1,4 - 二氢吡啶类药物伊拉地平与拉西地平与平滑肌钙通道相互作用的放射性配体及功能评估

Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

作者信息

Salomone S, Godfraind T

机构信息

Laboratoire de Pharmacologie, Université Catholique de Louvain, Bruxelles, Belgium.

出版信息

Br J Pharmacol. 1993 May;109(1):100-6. doi: 10.1111/j.1476-5381.1993.tb13537.x.

Abstract
  1. The present experiments were undertaken in order to characterize further the apparently irreversible inhibition of the contraction of depolarized rat aorta caused by lacidipine, a 1,4-dihydropyridine calcium antagonist. 2. We studied the effect of lacidipine on contraction evoked by 100 mM KCl solution in rat aorta, treated by N omega-nitro-L-arginine (0.1 mM), an inhibitor of nitric oxide (NO) synthesis. We compared the effect of prolonged depolarization on lacidipine and (+)-isradipine inhibition and the reversal of this inhibition after washout in the absence of dihydropyridines. Assuming that the onset of lacidipine-evoked inhibition was a pseudo-first order association kinetics, we estimated the dissociation rate constant (k-1 = 0.031 min-1), the association rate constant (k1 = 2.70 x 10(8) M-1 min-1) and the dissociation constant (KD = k-1/k1 = 115 pM) which was close to the IC50 value in steady-state conditions (160 pM). 3. The inhibitory effects of lacidipine and (+)-isradipine on rat aorta contraction were reversibly enhanced after preincubation with the drug in a 40 mM KCl-solution. Washout with drug-free 40 mM K(+)-depolarizing solution reversed inhibition in the (+)-isradipine-treated preparations, but not in the lacidipine-treated ones. 4. Radioligand binding studies were performed with [3H]-lacidipine and [3H]-isradipine in microsomes from rat aorta and rat ileum. Both ligands bound to a homogeneous population of binding sites (for[3H]-lacidipine: KD = 23 +/- 2.6 pM, Bmax = 380 +/- 21 fmol mg-1 protein in membranes from aorta; KD =23 +/- 3.1 pM, Bmax = 790 +/- 60 fmol mg-1 protein in membranes from ileum; for [3H]-isradipine:KD = 140 +/- 46 pM, Bmax = 350 +/- 64 fmol mg-1 protein in membrane from aorta; KD = 68 +/- 14 pM,Bmax = 760 +/- 75 fmol mg-1 protein in membranes from ileum). After isotopic dilution, [3H]-lacidipine and [3H]-isradipine dissociated according to a monoexponential kinetics. In membranes from ileum, the calculated dissociation rate constants (kappa_ 1) were 0.0257 min-1 and 0.0595 min-1, for [3H]-lacidipine and[3H]-isradipine, respectively.5. The non specific binding of [3H]-lacidipine and [3H]-isradipine, was measured in intact rat aorta preparations incubated under the conditions of the functional experiments, in the presence of nifedipine(1 microM). After incubation with [3H]-lacidipine 77.6 +/- 1.9 pM for 2 h the concentration of drug in the tissue was 15.15 +/- 1.18 fmol mg-1 w.wt. and still amounted to 7.24 +/- 0.61 fmol mg-1 w.wt. after 3.5 h washout in drug-free solution. After incubation with [3H]-isradipine 47.2 +/- 0.4 pM for 2 h it was 2.26 +/-0.07 fmol mg-1 w.wt. and was undetectable after 3.5 h washout in a drug-free solution.6. It is concluded that lacidipine interacts reversibly with dihydropyridine binding sites and that the apparent irreversible inhibition of contraction in depolarized preparations could be related to a nonspecific binding in a tissue compartment different from the plasma membrane.
摘要
  1. 本实验旨在进一步表征拉西地平(一种1,4 - 二氢吡啶类钙拮抗剂)对去极化大鼠主动脉收缩的明显不可逆抑制作用。2. 我们研究了拉西地平对经一氧化氮(NO)合成抑制剂Nω-硝基-L-精氨酸(0.1 mM)处理的大鼠主动脉中100 mM KCl溶液诱发的收缩的影响。我们比较了长时间去极化对拉西地平和(+)-异搏定抑制作用的影响,以及在不存在二氢吡啶类药物的情况下洗脱后这种抑制作用的逆转情况。假设拉西地平诱发抑制的起始为假一级缔合动力学,我们估计了解离速率常数(k - 1 = 0.031 min⁻¹)、缔合速率常数(k1 = 2.70×10⁸ M⁻¹ min⁻¹)和解离常数(KD = k - 1/k1 = 115 pM),其接近稳态条件下的IC50值(160 pM)。3. 在40 mM KCl溶液中预孵育药物后,拉西地平和(+)-异搏定对大鼠主动脉收缩的抑制作用可逆增强。用无药物的40 mM K⁺去极化溶液洗脱可逆转(+)-异搏定处理制剂中的抑制作用,但对拉西地平处理的制剂无效。4. 用[³H]-拉西地平和[³H]-异搏定在大鼠主动脉和大鼠回肠的微粒体中进行放射性配体结合研究。两种配体均与同质的结合位点群体结合(对于[³H]-拉西地平:KD = 23 ± 2.6 pM,主动脉膜中Bmax = 380 ± 21 fmol mg⁻¹蛋白质;KD = 23 ± 3.1 pM,回肠膜中Bmax = 790 ± 60 fmol mg⁻¹蛋白质;对于[³H]-异搏定:KD = 140 ± 46 pM,主动脉膜中Bmax = 350 ± 64 fmol mg⁻¹蛋白质;KD = 68 ± 14 pM,回肠膜中Bmax = 760 ± 75 fmol mg⁻¹蛋白质)。同位素稀释后,[³H]-拉西地平和[³H]-异搏定按单指数动力学解离。在回肠膜中,[³H]-拉西地平和[³H]-异搏定的计算解离速率常数(κ₁)分别为0.0257 min⁻¹和0.0595 min⁻¹。5. 在功能性实验条件下,在硝苯地平(1 μM)存在的情况下,在完整大鼠主动脉制剂中测量[³H]-拉西地平和[³H]-异搏定的非特异性结合。用[³H]-拉西地平77.6 ± 1.9 pM孵育2小时后,组织中的药物浓度为15.15 ± 1.18 fmol mg⁻¹湿重,在无药物溶液中洗脱3.5小时后仍为7.24 ± 0.61 fmol mg⁻¹湿重。用[³H]-异搏定47.2 ± 0.4 pM孵育2小时后为2.26 ± 0.07 fmol mg⁻¹湿重,在无药物溶液中洗脱3.5小时后无法检测到。6. 得出的结论是,拉西地平与二氢吡啶结合位点可逆相互作用,去极化制剂中收缩的明显不可逆抑制可能与不同于质膜的组织隔室中的非特异性结合有关。

相似文献

引用本文的文献

4
Cardioselectivity of calcium antagonists.钙拮抗剂的心脏选择性
Cardiovasc Drugs Ther. 1994 May;8 Suppl 2:353-64. doi: 10.1007/BF00877320.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验